We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+11.09%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$269B
AUM Growth
+$11B
(+4.3%)
Cap. Flow
-$7.32B
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
22.8%
Holding
3,195
New
25
Increased
1,065
Reduced
1,860
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 2 |
NVIDIA
NVDA
|
+$425M |
| 3 |
Boeing
BA
|
+$396M |
| 4 |
Linde
LIN
|
+$381M |
| 5 |
ExxonMobil
XOM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.4B |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$323M |
| 3 |
Accenture
ACN
|
+$264M |
| 4 |
Microsoft
MSFT
|
+$258M |
| 5 |
Union Pacific
UNP
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.06% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 11.54% |
| 4 | Consumer Discretionary | 10.68% |
| 5 | Industrials | 8.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
NovoCure
NVCR
$1.91B
| $18.1M | 0.01% |
301,382
-375
| -0.1% | -$30K |
|
1102
Ultragenyx Pharmaceutical
RARE
$2.55B
| $18.1M | 0.01% |
451,418
-12,951
| -3% | -$556K |
|
1103
Omnicell
OMCL
$1.68B
| $18M | 0.01% |
307,372
+8,170
| +3% | +$451K |
|
1104
Cabot Corp
CBT
$4.52B
| $18M | 0.01% |
235,126
-22,879
| -9% | -$1.72M |
|
1105
Amylyx Pharmaceuticals
AMLX
$2.54B
| $18M | 0.01% |
611,932
+15,878
| +3% | +$552K |
|
|
MODN
1106
DELISTED
MODEL N, INC.
MODN
| $17.9M | 0.01% |
535,678
+105,023
| +24% | +$3.83M |
|
1107
ATI
ATI
$31B
| $17.9M | 0.01% |
454,138
+23,718
| +6% | +$896K |
|
1108
Trex
TREX
$5.01B
| $17.9M | 0.01% |
367,885
+52,179
| +17% | +$2.64M |
|
1109
Portillo's
PTLO
$321M
| $17.9M | 0.01% |
837,409
+324,713
| +63% | +$6.82M |
|
1110
Hertz
HTZ
$809M
| $17.9M | 0.01% |
1,096,684
-49,980
| -4% | -$872K |
|
1111
Ferguson
FERG
$49.8B
| $17.8M | 0.01% |
+133,018
| New | +$18.5M |
|
1112
United Bankshares
UBSI
$6.62B
| $17.8M | 0.01% |
504,563
+107,729
| +27% | +$4.23M |
|
1113
Sensata Technologies
ST
$6.79B
| $17.7M | 0.01% |
354,712
+13,102
| +4% | +$634K |
|
1114
Advanced Drainage Systems
WMS
$10.9B
| $17.7M | 0.01% |
209,875
-28,896
| -12% | -$2.54M |
|
1115
Range Resources
RRC
$8.95B
| $17.6M | 0.01% |
666,480
-56,368
| -8% | -$1.42M |
|
|
UCB
1116
United Community Banks
UCB
$4.28B
| $17.6M | 0.01% |
627,093
-221,970
| -26% | -$7.01M |
|
1117
Alaska Air
ALK
$5.58B
| $17.6M | 0.01% |
419,804
+1,636
| +0.4% | +$76.8K |
|
1118
Harley-Davidson
HOG
$2.71B
| $17.6M | 0.01% |
463,798
+6,739
| +1% | +$296K |
|
1119
EnerSys
ENS
$6.99B
| $17.6M | 0.01% |
202,166
-7,945
| -4% | -$668K |
|
1120
Northwest Natural Holdings
NWN
$2.12B
| $17.5M | 0.01% |
368,641
-19,635
| -5% | -$949K |
|
|
SGI
1121
Somnigroup International
SGI
$13.7B
| $17.5M | 0.01% |
442,663
-12,183
| -3% | -$485K |
|
1122
Sabra Healthcare REIT
SBRA
$5.37B
| $17.5M | 0.01% |
1,520,011
-457,212
| -23% | -$5.66M |
|
1123
Antero Midstream
AM
$10.1B
| $17.5M | 0.01% |
1,663,609
-86,668
| -5% | -$922K |
|
1124
Casella Waste Systems
CWST
$5.69B
| $17.4M | 0.01% |
210,245
+19,160
| +10% | +$1.52M |
|
1125
Polaris
PII
$4.07B
| $17.3M | 0.01% |
156,742
+5,818
| +4% | +$645K |
|
Similar funds
VFT
Nuveen's Q1 2023 Portfolio in Review
As of Q1 2023, Nuveen held 3,195 positions worth $269B, up 4.3% from $258B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 3.3%. Nuveen opened 25 new positions and exited 81, leaving the 3,195-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q1 2023 buy was GE HealthCare: 1,240,905 shares worth $102M.
- Nuveen added most to Meta Platforms (Facebook) in Q1 2023, an estimated $1.08B increase.
- Nuveen's biggest Q1 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $1.4B.
- Nuveen fully exited SVB Financial Group in Q1 2023, selling an estimated $51.6M.
- Nuveen's ten largest holdings make up 23% of its $269B portfolio in Q1 2023.
- Nuveen opened 25 new positions and closed 81 in Q1 2023.
- Nuveen's portfolio value rose 4.3% quarter-over-quarter to $269B.
Based on Nuveen's 13F filing for Q1 2023, filed 15 May 2023.